Drug intelligence / Profile preview

metoprolol + carvedilol

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Oral
01

Overview

This entry refers to a comparative clinical study of metoprolol and carvedilol, conducted by Bispebjerg Hospital, focusing on patients with chronic heart failure and type 2 diabetes mellitus. Metoprolol is a cardioselective beta-1 adrenergic receptor antagonist, whereas carvedilol is a non-selective beta-blocker that also exhibits alpha-1 adrenergic receptor antagonism. The study (NCT00447512) evaluated the effects of these two beta-blockers on endothelial function and insulin-stimulated endothelial function. Carvedilol is hypothesized to have a more favorable effect on these parameters compared to metoprolol due to its vasodilatory and antioxidant properties, which may be particularly beneficial in patients with metabolic comorbidities like type 2 diabetes.

Other names
metoprololcarvedilol
02

Targets

ADRB1 (β1)ADRB2 (β2)ADRA1A (α1A)

Beyond the preview

Go deeper on metoprolol + carvedilol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metoprolol + carvedilol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call